Authors:
Blaheta, HJ
Ellwanger, U
Schittek, B
Sotlar, K
Maczey, E
Breuninger, H
Thelen, MH
Bueltmann, B
Rassner, G
Garbe, C
Citation: Hj. Blaheta et al., Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma, J INVES DER, 114(4), 2000, pp. 637-642
Authors:
Blum, A
Schlagenhauff, B
Stroebel, W
Breuninger, H
Rassner, G
Garbe, C
Citation: A. Blum et al., Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma - Results of a prospective study of 1288 patients, CANCER, 88(11), 2000, pp. 2534-2539
Authors:
Weide, B
Schittek, B
Klyscz, T
Schuz, K
Stark, M
Rassner, G
Wilske, B
Garbe, C
Citation: B. Weide et al., Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction, BR J DERM, 143(4), 2000, pp. 780-785
Authors:
Kuchelmeister, C
Schaumburg-Lever, G
Garbe, C
Citation: C. Kuchelmeister et al., Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients, BR J DERM, 143(2), 2000, pp. 275-280
Authors:
Hipfel, R
Schittek, B
Bodingbauer, Y
Garbe, C
Citation: R. Hipfel et al., Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization, BR J CANC, 82(6), 2000, pp. 1149-1157
Citation: Pg. Buettner et C. Garbe, Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination, AM J EPIDEM, 151(1), 2000, pp. 72-77
Citation: M. Moehrle et C. Garbe, Does mountaineering increase the incidence of cutaneous melanoma? A hypothesis based on cancer registry data, DERMATOLOGY, 199(3), 1999, pp. 201-203
Authors:
Blaheta, HJ
Schittek, B
Breuninger, H
Sotlar, K
Ellwanger, U
Thelen, MH
Maczey, E
Rassner, G
Bueltmann, B
Garbe, C
Citation: Hj. Blaheta et al., Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin, AM J SURG P, 23(7), 1999, pp. 822-828
Citation: B. Schittek et al., Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines, INT J CANC, 82(4), 1999, pp. 583-586
Authors:
Becker, J
Brocker, EB
Dummer, R
Enk, A
Garbe, C
Hauschild, A
Hein, R
Kaufmann, R
Krahn, G
Lohmann, F
Luther, H
Mauch, C
Mohr, P
Nashan, D
Neuber, K
Peter, RU
Reinhold, U
Schadendorf, D
Sebastian, G
Soyer, P
Stadler, R
Stolz, W
Tilgen, W
Trefzer, U
Tronnier, M
Ulrich, J
Volkenandt, M
Citation: J. Becker et al., Current position of the Working Group on Dermatological Oncology on high-dose therapy with interferon alpha 2b, HAUTARZT, 50(6), 1999, pp. 395-397
Authors:
Blum, A
Brand, CU
Ellwanger, U
Schlagenhauff, B
Stroebel, W
Rassner, G
Garbe, C
Citation: A. Blum et al., Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment, BR J DERM, 141(5), 1999, pp. 783-787
Authors:
Schittek, B
Bodingbauer, Y
Ellwanger, U
Blaheta, HJ
Garbe, C
Citation: B. Schittek et al., Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma, BR J DERM, 141(1), 1999, pp. 30-36
Authors:
Schittek, B
Blaheta, HJ
Florchinger, G
Sauer, B
Garbe, C
Citation: B. Schittek et al., Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction, BR J DERM, 141(1), 1999, pp. 37-43